IL-1 Signaling Cascade in Liver Cells and the Involvement of a Soluble Form of the IL-1 Receptor Accessory Protein
Open Access
- 15 May 2000
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 164 (10) , 5277-5286
Abstract
The proinflammatory cytokine IL-1 induces the biosynthesis of a number of immunologically important proteins during infection, tissue damage, and/or stress, in part through the activation of the transcription factor NF-κB. Signal transduction is initiated at the cell membrane by complex formation between extracellular IL-1 and the transmembrane IL-1R type I (IL-1RI) and IL-1R accessory protein (IL-1RAcP). The intracellular signaling cascade involves recruitment of two IL-1R-associated kinases, IRAK1 and IRAK2, and the adapter protein MyD88, events which are dependent on the intracellular domain of membrane-bound IL-1RAcP (mIL-1RAcP). In mouse liver, IL-1RAcP is expressed as a soluble protein (sIL-1RAcP), the function of which is unknown. We have cloned the human sIL-1RAcP and established by sequence analysis that the human sIL-1RAcP mRNA arises from alternative splicing of the IL-1RAcP gene (shown here to encompass 12 exons spanning more than 56 kb). Furthermore, we demonstrate that human HepG2 hepatoma cells express both mIL-1RAcP and sIL-1RAcP and that signal transduction in these cells is mediated through IRAK1, IRAK2, and MyD88. We show that phorbol esters induce a change in the pre-mRNA splice pattern such that sIL-1RAcP mRNA becomes the dominant form. Overexpression of a membrane-anchored fusion protein of sIL-1RAcP and MHC in HepG2 cells inhibits IL-1-mediated NF-κB activation, whereas coexpression of IL-1RI with membrane-anchored sIL-1RAcP restores the capacity of the cells to respond to IL-1. This suggests that sIL-1RAcP may act as an inhibitor of IL-1 by directly interacting with IL-1RI to abolish its capacity to transduce signal.Keywords
This publication has 44 references indexed in Scilit:
- Interleukin-1 Receptor Cluster: Gene Organization ofIL1R2, IL1R1, IL1RL2(IL-1Rrp2),IL1RL1(T1/ST2), andIL18R1(IL-1Rrp) on Human Chromosome 2qGenomics, 1999
- The Kinetics and Magnitude of the Synergistic Activation of the Serum Amyloid A Promoter by IL‐1β and IL‐6 is Determined by the Order of Cytokine AdditionScandinavian Journal of Immunology, 1999
- Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB ActivationCell, 1998
- The Human Gene Encoding the Interleukin-1 Receptor Accessory Protein (IL1RAP) Maps to Chromosome 3q28 by Fluorescencein SituHybridization and Radiation Hybrid MappingGenomics, 1998
- MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1Nature, 1997
- TRAF6 is a signal transducer for interleukin-1Nature, 1996
- Co‐expression of mRNA for type I and type II Interleukin‐1 receptors and the IL‐1 receptor accessory protein correlates to IL‐1 responsivenessFEBS Letters, 1996
- Genomic organization ot the type I and type II IL-1 receptorsCytokine, 1995
- The type II ‘decoy’ receptor: A novel regulatory pathway for interleukin 1Immunology Today, 1994
- HepG2 cells predominantly express the type II interleukin 1 receptor (biochemical and molecular characterization of the IL-1 receptor)Cytokine, 1992